Cochrane Abstracts
Rifabutin for treating pulmonary tuberculosis Unchanged
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rifabutin for Treating Pulmonary Tuberculosis Unchanged." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433920/all/Acid_reflux_treatment_for_hoarseness:_Cochrane_systematic_review. Accessed 05 June 2023.
Rifabutin for treating pulmonary tuberculosis Unchanged. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433920/all/Acid_reflux_treatment_for_hoarseness:_Cochrane_systematic_review. Accessed June 5, 2023.
Rifabutin for treating pulmonary tuberculosis Unchanged. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433920/all/Acid_reflux_treatment_for_hoarseness:_Cochrane_systematic_review
Rifabutin for Treating Pulmonary Tuberculosis Unchanged [Internet]. In: Cochrane Abstracts. [cited 2023 June 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433920/all/Acid_reflux_treatment_for_hoarseness:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rifabutin for treating pulmonary tuberculosis Unchanged
ID - 433920
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433920/all/Acid_reflux_treatment_for_hoarseness:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
